2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Matthias Griese: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD) Hydroxychloroquine sulfate, Placebo - Interstitial Lung Disease, Diffuse Parenchymal Lung Disease | Phase 2 | Terminated | Matthias Griese | 35 | 2015-08-21 | 2025-12-03 |
| Stop Exogenous Allergic Alveolitis (EAA) in Childhood Placebo, Prednisolone - Hypersensitivity Pneumonitis, Exogenous Allergic Alveolitis | Phase 2 | Terminated | Matthias Griese | 4 | 2015-04-01 | 2024-12-18 |
Alveolitis, Extrinsic Allergic (1) · Lung Diseases, Interstitial (1)
Hydroxychloroquine (1) · Methylprednisolone (1) · Prednisolone (1)
Germany (2)
Meike Hengst, MD (1)